The role of skin irritation and other factors on the tumorigenk activity of petroleum middle distillates (PMDs) in mice was examined in a comprehensive research program. The program culminated in a 2-year dermal cartinogenkity study which compared the effects of equal weekly doses of irritating and nonirritating PMDs. Modified Ames mutagenkity studies and three-to seven-ring polycyclic aromatic compound (PAC) analyses indicated that the mutagenic activity of PMDs was correlated to PAC content In subchronic and subacute studies, PMDs produced marked skin irritation which was ameliorated if the test samples were diluted in mineral oil. The reduction in irritation level was not a result of reduced dermal absorption. Straight-run kerosine (SRK), straight-run gas ofl (SRGO), and catalytfcally cracked light cycle oil (LCO) were evaluated in the dermal cardnogenidty study. Test materials were applied either undiluted (2x/week) or as 28^% (7x/week) or 50% (4x/ week) concentrations in mineral ofl for a total weekly dose of 100 /xi PMD per animaL All three materials produced moderate to marked skin irritation and increased tumor frequency when applied undiluted. When diluted, the irritant effects of SRK and SRGO, which contain low levels of PACs, were ameliorated, and there were no significant increases in tumors relative to controls. LCO, containing 8.7% three-to seven-ring PACs, increased tumor frequency when diluted, even when skin irritation was limited. These data indicate that the tumorigenic activity of straight-run MDs is likely a consequence of a nongenotoxk process, associated with frequent cell Hamagp and repair. PMDs which contain low levels of three-to seven-ring PACs are unlikely to cause tumors in the absence of prolonged skin irritation, hi addition, genotaric mechanisms may also contribute to tumor formation for other PMDs containing higher levels of PACs, e.g., products blended with cracked Petroleum middle distillates (PMDs), which include kerosine, jet fuel, and diesel fuel, are a class of hydrocarbons distilled from crude oil at approximately 350 to 700°F (176-' Current address: ToxWorks, Ringoes, NJ 08551.
A Comprehensive Evaluation of the Mechanism of Skin Tumorigenesis by Straight-Run and Cracked Petroleum Middle Distillates. Nessel, C. S., Priston, R. A. J., McKee, R. H., Cruzan, G., Riley, A. J., Hagemann, R., Plutnick, R. T., and Simpson, B. J. (1998) . ToxicoL Sci. 44, 22-31.
The role of skin irritation and other factors on the tumorigenk activity of petroleum middle distillates (PMDs) in mice was examined in a comprehensive research program. The program culminated in a 2-year dermal cartinogenkity study which compared the effects of equal weekly doses of irritating and nonirritating PMDs. Modified Ames mutagenkity studies and three-to seven-ring polycyclic aromatic compound (PAC) analyses indicated that the mutagenic activity of PMDs was correlated to PAC content In subchronic and subacute studies, PMDs produced marked skin irritation which was ameliorated if the test samples were diluted in mineral oil. The reduction in irritation level was not a result of reduced dermal absorption. Straight-run kerosine (SRK), straight-run gas ofl (SRGO), and catalytfcally cracked light cycle oil (LCO) were evaluated in the dermal cardnogenidty study. Test materials were applied either undiluted (2x/week) or as 28^% (7x/week) or 50% (4x/ week) concentrations in mineral ofl for a total weekly dose of 100 /xi PMD per animaL All three materials produced moderate to marked skin irritation and increased tumor frequency when applied undiluted. When diluted, the irritant effects of SRK and SRGO, which contain low levels of PACs, were ameliorated, and there were no significant increases in tumors relative to controls. LCO, containing 8.7% three-to seven-ring PACs, increased tumor frequency when diluted, even when skin irritation was limited. These data indicate that the tumorigenic activity of straight-run MDs is likely a consequence of a nongenotoxk process, associated with frequent cell Hamagp and repair. PMDs which contain low levels of three-to seven-ring PACs are unlikely to cause tumors in the absence of prolonged skin irritation, hi addition, genotaric mechanisms may also contribute to tumor formation for other PMDs containing higher levels of PACs, e.g., products blended with cracked 371°C). PMDs have been shown to cause skin rumors in mice following repeated and prolonged skin contact (Lewis et al, 1984; Biles et al, 1988; Clark et al., 1988) . A low tumor yield and long latency are characteristic of the tumorigenic response in mice.
The tumorigenic potential of PMDs was originally reported in studies by the American Petroleum Institute (API) following dermal administration of distillate fractions boiling between 120 and 700°F (49-371°C) (King, 1984; Lewis et al., 1984) . Certain polycyclic aromatic compounds (PACs) containing four to six rings have been identified as the carcinogenic constituents of higher boiling petroleum streams (Bingham et al., 1980; Roy et al, 1988) , but the middle distillate fractions contained undetectable or negligible concentrations of these PACs. Because the middle distillate fractions contained negligible concentrations of four-to six-ring PACs, it is considered unlikely that a genotoxic mechanism was responsible for the tumor development. Severe skin irritation was noted in the API studies, and it was suggested that this may have influenced the extent to which skin tumors were produced (Ingram and Grasso, 1991) .
Petroleum middle distillates may be categorized into two general classes: straight-run and cracked. Straight-run PMDs, which include kerosines and gas oils, are produced from the distillation of crude oil at atmospheric pressure. Alternatively, it is possible to produce hydrocarbons of similar boiling range by processes which break down larger and more complex molecules by catalytic or thermal methods (generically referred to as "cracking"). Certain products, including diesel fuels and home heating oils, may contain components produced from various cracking processes in addition to straight-run material. PACs are typically found in very low concentrations in straight-run PMDs, but are generated in the cracking process and hence are often found at higher levels in PMD products which contain cracked blend streams.
Many studies have investigated the mechanism of middle distillate carcinogenesis. These studies indicate that straightrun PMDs generate skin tumors through a nongenotoxic mechanism. Straight-run PMDs have been found to have low or no 64742-W-9 8008-20-6 64742-81-0 64742-81-0 8008-20-6 64742-46-7 64741-59-9 64742-81-0/64741-77-1 activity in the modified Ames Salmonella mutagenicity assay (McKee et al, 1989 Deininger et al, 1991) , lack tumor initiating activity (McKee et al., 1989; Jungen et al., 1995) , and are active skin tumor promoters (McKee et al., 1989; Skisak, 1991; Nessel et al, 1996) . It has been hypothesized that the skin tumors associated with these materials may be due to the promotion of preexisting, spontaneously initiated cells .
Petroleum middle distillates cause chronic skin irritation and injury with repeated application to the skin (Witschi et al., 1987; Clark et al., 1988; Grasso et al., 1988; Freeman et al, 1990) . The irritation is characterized in part by epidermal hyperplasia. Several authors have hypothesized that mouse skin tumors may arise as a secondary response to chronic skin irritation (McKee et al, 1989; Ingram et al, 1993) . Dilution and intermittent dosing studies indicated that chronic skin irritation was a necessary condition for tumor induction by PMDs .
A comprehensive test program was initiated by CONCAWE (The Oil Companies' European Organization for Environment, Health and Safety) to evaluate the role of skin irritation and other factors in the tumorigenic response of mouse skin following repeated PMD application. This three-phase program included analytical and mutagenicity studies, short-term and subchronic studies to evaluate the irritant effect and dermal penetration of PMDs, and a 2-year dermal carcinogenicity study in mice. Some of the skin irritation studies have been previously reported (Grasso et al, 1988; Ingram et al, 1993) . In the chronic study, the role of skin irritation on the tumorigenic activity of three PMDs (two straight-run and one catalytically cracked) was examined by comparing the effects of irritating undiluted PMDs with equal weekly doses of the same materials diluted in a nonirritating mineral oil.
METHODS

Test Materials
Ten samples were included in the first phase of the study, and samples for subsequent phases of the study were selected from among the original samples. The 10 samples included a hydrotreated naphtha/white spirit, 5 kerosines, and 4 gas oils and are listed in Table 1 . Table 1 also shows the samples that were subsequently tested in phases 2 (subchronic/dermal penetration studies) and 3 (2-year skin carcinogenesis bioassay) of the research program. In the 2-year study, a catalytically cracked clarified oil identified as heavy clarified oil (HCO) was used as a positive control, and a highly refined mineral oil (MO) was used as the negative control.
Pkysicochemical Analyses of Samples
Analytical and physicochemical data (e.g., boiling range, chemical analysis) were collected prior to initiation of the biological studies. The content of threeto seven-ring PACs was determined by the method of Roy et al. (1988) . This analytical method provides a quantitative measure of the content of three-to seven-ring PACs in a sample. This PAC fraction will contain both biologically active PACs and noncarcinogenic PACs. An analysis by Roy et al (1988) indicated that petroleum products containing £1% three-to seven-ring PACs, as measured by this method, were not biologically active in dermal carcinogenesis studies.
Phase One Studies
Modifitd AIMS Salmonella assays. The mutagenic potential of the test materials was determined in the modified Ames Salmonella assay by the method of Blackburn et al. (1984; 1986) .
Histopathologic evaluation of skin following multiple exposures. Two studies were carried out to examine early dermal changes produced by skin application of PMDs to mice. In the first study, three PMDs (MD-1, MD-4, and MD-11) were applied (100 fd/dose) to mouse skin 3X/week for 6 weeks, while seven PMDs (MD-1, MD-3, MD-4, MD-6, MD-7, MD-8, and MD-11) were applied to mouse skin three times at 3-day intervals in the second study. Control materials, including several mineral oils, croton oil, and benzo-[a]pyrene, were also examined. A more complete description of the histopathological evaluation is described in Grasso et al. (1988) . " Erythema was graded as slight, moderate, or marked. Edema was graded as slight or moderate/marked. All other signs of irritation were recorded as present or not present. Animals could exhibit several signs of irritation at one time, but the irritation score for each animal was based on the single most severe sign of irritation (i.e., maximum score = 4). The irritation index for each treatment group was calculated as Irritation index = Sum of the single highest score for dermal irritation for each animal/Number of animals in group.
Phase Two Studies
Thirteen-week dermal study. In order to establish appropriate dosing conditions for a long-term study, five PMD samples (MD-1, MD-3, MD-6, MD-7, and MD-8) were tested in a 13-week dermal study in C3H mice. Test samples were applied undiluted or as 25, 50, or 75% dilutions in acetone or mineral oil to groups of six mice. Undiluted PMDs were administered either once (100 /xl) or twice (50 /xl) per week. Diluted PMDs were administered twice weekly (50 /xl). Control mice (n = 12) received acetone or mineral oil. Irritation was evaluated by clinical observation during the study, by gross changes at postmortem, and by histopathologic assessment of treated areas at necropsy. Skin irritation was semiquantified; briefly, an irritation index (II) of 0-4 was calculated for each treatment group based on gross signs of skin irritation as shown in Table 2 .
Six-week dermal study. A six-week dermal study in C3H mice was conducted to determine the maximum number of doses of PMDs that could be applied per week without producing excessive dermal irritation. Two samples (MD-3 and MD-8) were diluted to 25 or 50% in mineral oil and applied 4X and 7X/week to groups of 10 mice. Control mice received mineral oil 4X or 7X/week. Skin irritation was assessed visually using the scoring system presented in Table 2 .
Dermal penetration study. A dermal penetration study was conducted to confirm that dilution in mineral oil did not reduce the absorption of PMDs through the skin. Groups of five C3H mice were exposed for 96 h to a single dose of neat or 25% concentrations of PMDs (MD-1 or MD-8) in mineral oil containing [
M C]tetradecane and [ M C]naphthalene as surrogates to measure absorption. Urine and feces were collected at 24, 48, 72, and 96 h after administration, and at termination, carcasses were homogenized for determination of tissue accumulation. Separate groups were examined for radiolabelled CO 2 in expired air and control groups were included to account for potential passive accumulation of radiolabeled compounds by inhalation.
Phase Three Study
Dermal carcinogenicity study. The results of the phase two studies indicated that it was possible to carry out a lifetime dermal application study of PMDs wimout producing excessive skin irritation. Three test materials, straight-run kerosine (SRK; MD-3), straight-run gas oil (SRGO; MD-6), and light cycle oil (LCO; MD-7), were examined in a chronic study to assess the influence of skin irritation on tumor development Test materials were applied in 50-/il aliquots to the backs of groups of 50 male C3H mice for up to 2 years as indicated in Table 3 . PMDs were applied undiluted (2x/week) or as 50% (4X/week) or 28.5% dilutions (7X/week) in mineral oil for a total weekly dose of 100 /xl test sample per animal. Highly refined mineral oil (MO) and 5% heavy clarified oil (HCO) were used as the negative and positive controls, respectively.
Male C3H/HeNCrlBR mice were obtained from Charles River Laboratories, Inc. (Raleigh, NC) and acclimated for 20 days prior to dosing. Animals were randomly assigned to control and experimental groups of 50 mice each. Mice were singly housed in stainless-steel cages with perforated bottoms, and lighting was maintained on a 12-h light-dark cycle. Animals were allowed access to water and commercial rodent chow (PMI Feeds Inc., Richmond, IN) ad libitum. Room temperature and relative humidity were controlled to 68-76°F and 40-70%, respectively.
Mice were examined for viability twice daily. Tumors were counted and grossly diagnosed on a weekly basis and histologically confirmed following termination of the study. Animals were examined for skin irritation weekly, beginning prior to dose initiation on day 0. Skin irritation was semiquantified according to the evaluation system presented in Table 2 .
Animals were euthanized when considered moribund, when suspected of (Blackburn et aL, 1986) . *ND, not detected (detection limit <0.1%). c NA, not available. having a carcinoma, or after 104 weeks of treatment and were subject to a detailed and gross examination. Skin masses, tumors, and samples of treated and untreated skin were retained and processed for histopathologic examination.
A review of dermal carcinogenicity studies on petroleum hydrocarbons has shown that papillomas and squamous cell carcinomas are the only tumor types clearly associated with dermal application of these materials . Therefore, although all data are shown in the tables, only tumors of these types are considered treatment-related and are counted toward total tumor numbers and statistical evaluations.
Statistics
The tumor analyses were performed using the Thomas, Breslow, and Gart analysis which tests for both incidence (jf and Fisher tests) (Bradley, 1968) and survivorship corrected for tumor incidence (Cox tests and Gehan-Breslow/ Kruskal-Wallis analyses) (Thomas et al, 1977) .
RESULTS
Phase One Studies
Modified Ames assays and physicochemical analyses. A summary of the results of modified Ames assays, three-to seven-ring PAC and total aromatic hydrocarbon analyses, and boiling range determinations is shown in Table 4 . The naphtha/ white spirit and all of the kerosines had PAC concentrations less than 0.1% and none of these samples were mutagenic in the modified Ames assay. The mutagenic activities of gas oils, light cycle oil, and the gas oil/LCO blend were proportional to the concentration of three-to seven-ring PACs. These PACs distill at temperatures above 350°C. The results are consistent with this principle, since three-to seven-ring PACs were only found at greater than 1% concentrations in MD-6, MD-7, MD-10, and MD-11, all of which have a final boiling point above this temperature. LCO (MD-7), which is both high boiling and catalytically cracked, had the greatest concentration of three-to seven-ring PACs and was the most mutagenic of the test samples.
Histopathological changes in skin following multiple exposures. Repeated application of PMDs to the shaved backs of mice resulted in severe localized skin damage, followed by epidermal hyperplasia. Effects were well advanced within 1-2 weeks. The distillate with the lowest boiling point, naphtha/ white spirit, was the most irritating of the test samples, causing widespread epidermal necrosis. Higher boiling kerosines and gas oils initially caused inflammation of the skin and necrosis of hair follicles, followed by degenerative changes. While the pattern of effects was similar, the relative severity of skin damage for these materials was as follows: LCO > kerosines > gas oils.
Phase Two Studies
Thirteen-week dermal study. Consistent with the findings in phase one, all five test samples (naphtha/white spirit, SRK, SRGO, LCO, and kerosine blend) caused moderate to severe skin irritation when applied undiluted, regardless of volume and dosing frequency (100 /xl once per week or 50 pi 2X/ week). Dilution in acetone did not significantly alter the degree of irritation, but dilution in mineral oil resulted in a clear concentration-related reduction in skin irritation for all test materials (Fig. 1) . Test samples produced no irritation to very slight irritation (mean n, 0.1) at 25% concentrations, no irritation to moderate irritation (mean n, 1.0) at 50% concentrations, and moderate irritation (mean II: 2.5) at 75% concentrations. The mean II of-the five PMDs when applied undiluted was 5.2.
Six-week dermal study. To better define the amount of PMD which could be applied per week in a long-term skin painting study, a 6-week dermal study was conducted. Straightrun kerosine (MD-3) and straight-run/hydrocracked kerosine blend (MD-8) were diluted in mineral oil to concentrations of 25 or 50% and applied for 6 weeks. Neither test material produced any visible skin irritation when applied 4 or 7 times per week at a 25% concentration (Table 5) . Only slight irritation (desquamation) was produced when the materials were administered at a 50% concentration four times weekly. This study indicated that PMDs diluted to 25%, applied daily, would not produce skin irritation in a long-term skin painting study. Therefore, equal weekly doses of diluted (25-50%, 4-7X/ week) and undiluted (2X/week) PMDs could be applied over a 2-year period, thus allowing direct comparison of the tumorigenic effects of PMDs at a constant dose but with varying levels of skin irritation.
Dermal penetration study. To confirm that dilution in mineral oil did not reduce the bioavailability of PMDs through the skin, an absorption study was conducted using 1 . Effect of dilution in mineral oil on the level of skin irritation produced by petroleum middle distillates in a 13-week dermal study. Test materials were applied undiluted (100%) and as 25, 50, and 75% concentrations in mineral oil. Irritation is presented as the mean irritation index over weeks 4-13 after the initial exposure. Skin irritation was scored from 0 to 4 based on the evaluation system shown in Table 2. tion of either neat or 25% concentrations of naphtha/white spirit (MD-1) and kerosine blend (MD-8) in mineral oil (Table  6 ). Approximately 12 and 15% of the [ 14 C]naphthalene was absorbed following dermal application of naphtha/white spirit and kerosine blend, respectively. Slightly more [
14 C]tetradecane was absorbed when the test materials were administered as a 25% dilution (7.1-8.6%) than when administered neat (5.2-5.4%). These results confirmed that dilution in mineral oil did not inhibit dermal penetration of PMD components.
Phase Three Carcinogenicity Study
SRK, SRGO, and LCO were tested at 28.5% (7X/week), 50% (4X/week), and 100% (2X/week) concentrations in a 2-year dermal carcinogenicity study in mice. Highly refined mineral oil and 5% HCO served as the negative and positive controls, respectively.
Survival. The pattern of mortality in PMD-treated groups was generally similar to that of the negative control group. As determined by method shown in Table 2 . * MO, mineral oil; SRK, straight-run kerosine (MD-3) ; KB, kerosine blend (MD-8). c NI, no irritation. Approximately half of the negative control mice died by week 80 and only two mice survived to the end of the study. Slightly higher mortality was observed in groups of mice treated with undiluted PMDs than in groups administered PMDs at 28.5 or 50% concentrations. There were no significant differences in survival between groups exposed to different PMDs. HCOtreated mice had the lowest survival rate. All animals in this group were euthanized by week 60, all but three due to the presence of tumors. Dermal irritation. The degree of dermal irritation was assessed on a scale of 0-4 (Table 2) for each surviving animal on a weekly basis. The time course of dermal irritation, expressed as the weekly irritation index, for each treatment group is shown graphically in Fig. 2 . The mean irritation index for each group over the course of the study (post-week 4) is shown in Fig. 3 . Treatment with undiluted SRK or SRGO resulted in moderate to marked skin irritation. These materials caused only very slight irritation in the 50% groups, and there was essentially no irritation in the groups treated with 28.5% SRK or SRGO. In contrast, LCO caused skin irritation in all treated groups. Neat LCO caused moderate to marked skin irritation, 50% LCO caused moderate irritation, and 28.5% LCO caused slight irritation.
Tumorigenic activity. There were no significant treatmentrelated gross findings at necropsy other than skin irritation and/or tumor development at the site of application. Benign and malignant skin tumors were produced in several groups (Table 7 and Fig. 3) . No tumors were found in mice treated with mineral oil. Nearly all mice (47/50) treated with 5% HCO developed tumors, indicating that these mice were capable of responding to a known skin carcinogen. Undiluted SRK (12/ 50) and SRGO (4/50) caused a statistically significant increase in tumor incidence, but there was no significant increase in tumor incidence in groups treated with diluted SRK or SRGO. No mice treated with 28.5 or 50% SRK or 50% SRGO developed tumors, while only a single tumor occurred in the group treated with 28.5% SRGO.
Tumors occurred in all groups treated with LCO. Only one mouse treated with 100% LCO developed a tumor, but 17 and 7 mice, respectively, in the 50 and 28.5% LCO groups developed papillomas or squamous cell carcinomas.
DISCUSSION
This three-phase research program was designed to investigate several factors which may influence the dermal tumor development in mice caused by repeated application of PMDs. Previous studies had identified chemical composition, including PAC content, and skin irritation as key elements which were related to tumorigenic activity (Lewis et al., 1984; Ingram and Grasso, 1991; . The mechanism of tumor formation is important for hazard classification (as required by the European Union Dangerous Substances Directive) and human health risk assessment.
The objective of phase one of the research program was to chemically characterize ten PMDs, assess their mutagenic activity, and evaluate their skin irritation potential. Undiluted PMDs were severely irritating when applied repeatedly to skin, with significant histopathological effects observed within 2 weeks. The lower viscosity materials were the most irritating.
The mutagenic activities of PMDs correlated with their three-to seven-ring PAC content. PMDs that contained no more than low levels of these PACs were not mutagenic, whereas those with higher levels of three-to seven-ring PACs had mutagenic activity. These results are consistent with those of Deininger et al. (1991) , who evaluated the mutagenic activity and PAC content of 24 straight-run and cracked PMDs.
Results from the second phase of the research program demonstrated that skin irritation could be reduced to minimal levels when straight-run PMDs were diluted to 25-50% concentrations in a nonirritating highly refined mineral oil. Skin Comparison of dermal irritation and skin tumor incidence caused by petroleum middle distillates in a 2-year dermal carcinogenicity study. Petroleum middle disullates tested were straight-run kerosine (SRK), stnught-run gas oil (SRGO), and light cycle oil (LCO). Mineral oil and 5% heavy clarified oil (HCO) were used as controls. Tumor incidence was based on the number of mice (/i = 50) with historically confirmed squamous cell carcinomas or dermal papillomas. Dermal irritaUon is expressed as the mean irritation index over the course of the study (post-week 4). irritation was minimal even when diluted PMDs were applied 4-7X/week. No more than very slight irritation developed at the same total weekly dose of PMDs which caused marked skin irritation when applied neat. Dilution in mineral oil did not affect dermal absorption of the PMDs. These results were used as the basis for the study design used in the third phase of the program, the dermal carcinogenicity bioassay. The dosing regimen used in this study allowed for a comparison of the tumorigenic activity of equal weekly doses of irritating (undiluted) , minimally irritating (50% dilution), and nonirritating (28.5% dilution) PMDs.
In the dermal carcinogenicity study, administration of SRK and SRGO resulted in increased tumor frequency, but only in the presence of significant skin irritation. Undiluted SRK and SRGO caused moderate to marked skin irritation and tumor incidences of 24 and 8%, respectively. When diluted to 28.5 and 50% concentrations in mineral oil, SRK and SRGO produced no more than very slight skin irritation and no significant increase in tumor incidence. These results indicated that the tumor development caused by straight-run PMDs is likely due to a nongenotoxic mechanism.
The catalytically cracked LCO contained a significant quantity of three-to seven-ring PACs and caused development of skin tumors, even at a concentration (28.5%) which did not cause appreciable skin irritation. LCO was mutagenic, so the tumorigenic activity of this material may have included a genotoxic mechanism. Surprisingly, only a single tumor developed in the group of mice which received undiluted LCO. However, this material caused significant skin irritation which, unlike the straight-run PMDs, was not totally eliminated by dilution in mineral oil. It is thought that the low tumor incidence of undiluted LCO may have resulted from a cytotoxic effect, causing cell death and preventing skin tumor formation. The decreased tumorigenic activity of petroleum materials due to their cytotoxicity has been shown in other studies (Wilson and Holland, 1982) .
This study indicated that repeated application of PMDs that contain undetectable or low levels of PACs to mouse skin will ' Number of animals with specified tumor/total number of tumors per group.
• Statistically different from negative control at p < 0.05. ** Statistically different from negative control at p < 0.01. produce tumors only if there is also prolonged moderate to marked skin irritation. The tumor development is likely a result of a nongenotoxic process and may result from frequent cell damage and repair. Thus, straight-run and PMD products which contain low levels of PACs are unlikely to cause rumors in the absence of prolonged and repeated skin irritation. Cracked PMDs which contain significant concentrations of three-to seven-ring PACs likely also produce skin tumors via additional, possibly genotoxic, mechanisms.
